ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 200 filers reported holding ARGENX SE in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,124,358 | +26.5% | 2,287 | -2.6% | 0.00% | 0.0% |
| Q4 2022 | $889,000 | -10.7% | 2,348 | -16.7% | 0.00% | 0.0% |
| Q3 2022 | $995,000 | -75.3% | 2,818 | -77.9% | 0.00% | -75.0% |
| Q1 2022 | $4,027,000 | -44.4% | 12,770 | -42.7% | 0.00% | -33.3% |
| Q4 2021 | $7,238,000 | +104.2% | 22,284 | +89.8% | 0.01% | +100.0% |
| Q3 2021 | $3,545,000 | +11.2% | 11,738 | +10.9% | 0.00% | -25.0% |
| Q2 2021 | $3,188,000 | +37.4% | 10,588 | +25.6% | 0.00% | 0.0% |
| Q1 2021 | $2,321,000 | – | 8,428 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |